Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6167)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 21, 2022 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Silk T, Silk M, Wu J. Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma. World J Gastroenterol 2022; 28(23): 2561-2568 [PMID: PMC9254139 DOI: 10.3748/wjg.v28.i23.2561] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i23/2561.htm |
| Number | Citing Articles |
| 1 |
Zhan‐cheng Qiu, You‐wei Wu, Wei‐li Qi, Chuan Li. PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP‐negative hepatocellular carcinoma patients after liver resection. Cancer Medicine 2024; 13(1) doi: 10.1002/cam4.6835
|
| 2 |
Multidisciplinary Approach Towards Managing Hepatocellular Carcinoma - Experience of a Single Hepatobiliary Center. Journal of Health and Rehabilitation Research 2024; 4(3): 1 doi: 10.61919/jhrr.v4i3.1650
|
| 3 |
Pamela Scarlett Espinoza Loyola, Diana Laura Muratalla Bautista, Karen Adela Hernández Bautista, Elizabeth Gil White, José Antonio González Moreno, Daniel Angel Torres del Real, Víctor Manuel Páez Zayas, Carla Escorza-Molina, Fernando Mondragón Rodríguez, Omar Vásquez Gómez, Luis Jorge Fernández López, Paul Santiago Mogrovejo Vázquez, Isidoro Aczel Sánchez-Cedillo, Víctor Jose Visag Castillo. Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: Review and bibliometric. iLIVER 2024; 3(1): 100077 doi: 10.1016/j.iliver.2024.100077
|
| 4 |
Hongmin Zhang, Jian Xu, Haoyu Meng, Lujun Shen. Comparison of the Effectiveness of Transarterial Bland Embolization and Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Propensity Score–Matched Study of 1,008 Patients. Journal of Vascular and Interventional Radiology 2025; 36(1): 41 doi: 10.1016/j.jvir.2024.09.005
|
| 5 |
Shun Cheng Chang, Chien Fu Liu, Marta Misztal, Yi Hsien Hsieh, Che Lin. A Multi-phase Deep Learning Approach for Predicting HCC Response to TACE using Complete Computed Tomography. 2023 IEEE EMBS Special Topic Conference on Data Science and Engineering in Healthcare, Medicine and Biology 2023; : 99 doi: 10.1109/IEEECONF58974.2023.10405004
|
| 6 |
Wen Chen, Hai-Tao Yan, Jin-Xing Zhang, Chun-Gao Zhou, Jin Liu, Sheng Liu, Hai-Bin Shi, Yuan Cheng, Qing-Quan Zu. Transarterial chemoembolization combined with molecular targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma beyond the up-to-seven criteria: a propensity score-matching analysis. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2419993
|
| 7 |
Jason K. Wong, Howard J. Lim, Vincent C. Tam, Kelly W. Burak, Laura A. Dawson, Prosanto Chaudhury, Robert J. Abraham, Brandon M. Meyers, Gonzalo Sapisochin, David Valenti, Setareh Samimi, Ravi Ramjeesingh, Amol Mujoomdar, Ilidio Martins, Elijah Dixon, Maja Segedi, David M. Liu. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews 2023; 115: 102526 doi: 10.1016/j.ctrv.2023.102526
|
| 8 |
Daenielle Lang, Rajiv Agarwal, Sara A. Brown, Anthony J. Borgmann, Natalie A. Lockney, Laura W. Goff, Thatcher R. Heumann. Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma. Advances in Oncology 2024; 4(1): 247 doi: 10.1016/j.yao.2024.02.002
|
| 9 |
Kyoko Oura, Asahiro Morishita, Tomoko Tadokoro, Koji Fujita, Joji Tani, Hideki Kobara. Immune Microenvironment and the Effect of Vascular Endothelial Growth Factor Inhibition in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(24): 13590 doi: 10.3390/ijms252413590
|